KaiPharm Overview
- Year Founded
-
2018
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
KaiPharm General Information
Description
Developer of a biotech platform designed for drug discovery and development. The company's platform analyzes drug-induced transcriptome data and allows monoclonal antibody analysis, and identification of novel indications for a given drug, enabling pharmaceutical industries to stay ahead through a combination of information technology and laboratory science.
Contact Information
Website
www.kaipharm.comCorporate Office
- Ewha Womans University Science Hall A-206
- 52, Ewhayeodae-gil, Seodaemun-gu
- Seoul, 03760
- South Korea
Corporate Office
- Ewha Womans University Science Hall A-206
- 52, Ewhayeodae-gil, Seodaemun-gu
- Seoul, 03760
- South Korea
KaiPharm Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Out of Business | 06-Oct-2024 | Completed | Out of Business | |||
| 4. Early Stage VC (Series A) | 10-Feb-2020 | Completed | Generating Revenue | |||
| 3. Seed Round | 01-Aug-2019 | Completed | Generating Revenue | |||
| 2. Angel (individual) | 01-Mar-2019 | $200K | $200K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 01-Nov-2018 | Completed | Generating Revenue |
KaiPharm Patents
KaiPharm Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024085557-A1 | Composition for preventing or treating oscar-induced diseases, comprising adefovir as active ingredient | Inactive | 19-Oct-2022 | ||
| WO-2024085558-A1 | Composition for preventing or treating oscar-induced diseases, containing brivudin as active ingredient | Inactive | 19-Oct-2022 | ||
| WO-2023191166-A1 | Prediction method and analysis device for drug adverse reactions to target drug | Inactive | 29-Mar-2022 | ||
| US-20220238189-A1 | Method of extracting drug information based on bioactivity data, method of constructing drug screening library, and analysis apparatus | Inactive | 25-Jan-2021 | G16C20/62 |
KaiPharm FAQs
-
When was KaiPharm founded?
KaiPharm was founded in 2018.
-
Where is KaiPharm headquartered?
KaiPharm is headquartered in Seoul, South Korea.
-
What industry is KaiPharm in?
KaiPharm’s primary industry is Discovery Tools (Healthcare).
-
Is KaiPharm a private or public company?
KaiPharm is a Private company.
-
What is KaiPharm’s current revenue?
The current revenue for KaiPharm is .
-
How much funding has KaiPharm raised over time?
KaiPharm has raised $6.15M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process